Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines.What you'll get out of this episode:Discussion on innovative CNS drug development on BioBreakthroughs podcast.Learn about Praxis' genetics-inspired approach to tackling complex brain diseases.Souza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE studies.Discover Praxis Precision Medicines' future prospects and their commitment to revolutionizing patient care in the CNS field.To learn more about our guests and their companies:LinkedIn: https://www.linkedin.com/in/marcio-souza-2b02837/Company LinkedIn: https://www.linkedin.com/company/praxis-precision-medicines-inc/Website: https://praxismedicines.com/Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Ver todos los episodios